Healthcare Providers and Services
Company Overview of Pathway Genomics Corporation
Pathway Genomics Corporation, a genetic testing laboratory, provides genetic tests in the United States and internationally. The company offers physicians with genetic testing reports on diet and exercise, drug response, carrier status, and complex health conditions. It offers testing services for specific conditions and traits, such as aerobic capacity (VO2max), asthma, beta thalassaemia, cystic fibrosis, Type 1 and Type 2 diabetes, eating behaviors, exercise response, food reactions, hypertension, matching diet type, metabolic health factors, Omega-6 and Omega-3 levels, rheumatoid arthritis, statin and warfarin response, vitamin C, and others. The company also provides DNA reports that off...
4045 Sorrento Valley Boulevard
San Diego, CA 92121
Founded in 2008
Key Executives for Pathway Genomics Corporation
Chief Technology Officer and Vice President of Engineering & Product Development
Compensation as of Fiscal Year 2013.
Pathway Genomics Corporation Key Developments
Pathway Genomics Names Robert C. Verfurth as Vice President of Sales
Nov 7 13
Pathway Genomics Corporation announced it has appointed Robert C. Verfurth as vice president of sales. Based at Pathway Genomics' San Diego headquarters, in this executive management position, Verfurth will assume responsibility for leading the company's U.S. sales division. Throughout his career, Verfurth has played an integral, frontline role in transforming early-stage sales teams into highly profitable sales forces. He was the vice president of sales at Dianon Systems, which LabCorp purchased for $598 million in 2003, as well as Prometheus Laboratories where he built the sales team into a mature, high revenue-generating industry force. While at Prometheus Laboratories, Verfurth also built a managed care team focused on the insurance payer market, which contributed to the purchase of the company in 2011 by Nestlé Health Science for more than $500 million.
Pathway Genomics Corporation Receives New York State Clinical Laboratory Permit
Oct 28 13
Pathway Genomics Corporation announced it has received a Clinical Laboratory Permit from the New York State Department of Health. The permit allows authorized health care providers in the state of New York the ability to offer their patients Pathway Fit(R), the company's diet, metabolism, and exercise genetic test. Considered one of the most rigorous control standards in the country, the validation process required for a New York State Clinical Laboratory Permit is designed to ensure reliable, accurate clinical laboratory services. Obtaining a New York State Clinical Laboratory Permit is an exciting benchmark in Pathway's growth and a testament to the quality, reliability and accuracy of Pathway's services. Pathway Fit analyzes genes associated with food metabolism and exercise response, and it provides actionable recommendations that aim to help people maintain a healthy weight -- and lose unhealthy weight - by tailoring their diet and exercise plans to their genetics. The only test of its kind available in New York, Pathway Fit provides physicians and patients with a critical new tool to help combat rising obesity rates. According to the CDC, 60% of New York's adults 18 years old and over are overweight, and approximately 24% are obese. Additionally, the New York State Department of Health reports that one-third of school-age children in New York State -- not including New York City -- are overweight or obese.
Pathway Genomics Corporation Names Karl Odquist as Executive Director of Managed Care
Aug 15 13
Pathway Genomics Corporation announced it has appointed Karl Odquist as executive director of managed care. Based at Pathway Genomics' San Diego headquarters, Odquist will be responsible for managed care contracting, reimbursement, government affairs, and clinical evidence generation for the company's diagnostic services. Odquist has more than 20 years of experience working with payers in the pharmaceutical and medical benefit side of the health care field. Prior to joining Pathway Genomics, he served in various leadership roles for leading pharmaceutical and diagnostic companies, including Prometheus Laboratories, where he directed multiple internal and external high-performing field-based teams, helping the company to achieve more than $500 million in annual net revenue.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|